HIGHLIGHTS
- who: Zhaohui Chu from the Nagoya Universit, Japan, The State University of have published the article: Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature review, in the Journal: (JOURNAL)
- future: Investigation will be required to identify if this observation was coincidental or if there is an association between this mutation and CBM.
SUMMARY
In the present case, the missense mutation in PIK3CA (exon Frontiers in Oncology frontiersin.org 10.3389/fonc . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.